Verona Pharma plc
Total Trades
94
Buys
6
Sells
72
Largest Trade
N/A
Insiders
13
Institutional Funds
1
Inst. Value
$100K–$500K
Activist Filings
34
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Rickard Kathleen A. | Chief Medical Offi… | SELL | $100K–$500K | 59K | $1.92 | Nov 4, 2023 |
| Rickard Kathleen A. | Chief Medical Offi… | SELL | $100K–$500K | 80K | $2.53 | Aug 8, 2023 |
| ZACCARDELLI DAVID | President and CEO | SELL | $500K+ | 276K | $2.52 | Aug 8, 2023 |
| Hahn Mark W | CFO | SELL | $500K+ | 276K | $2.52 | Aug 8, 2023 |
| Poll Claire | General Counsel | SELL | $100K–$500K | 48K | $2.52 | Aug 8, 2023 |
| Hahn Mark W | CFO | SELL | $100K–$500K | 180K | $2.64 | Aug 4, 2023 |
| Poll Claire | General Counsel | SELL | $50K–$100K | 32K | $2.64 | Aug 4, 2023 |
| ZACCARDELLI DAVID | President and CEO | SELL | $100K–$500K | 180K | $2.64 | Aug 4, 2023 |
| Rickard Kathleen A. | Chief Medical Offi… | SELL | $50K–$100K | 33K | $2.64 | Aug 4, 2023 |
| ORBIMED ADVISORS LLC | Director | SELL | $1M+ | 483K | $20.58 | May 15, 2023 |
| Gupta Rishi | Director | SELL | $1M+ | 483K | $20.58 | May 15, 2023 |
| Poll Claire | General Counsel | SELL | $100K–$500K | 80K | $2.58 | May 3, 2023 |
| Rickard Kathleen A. | Chief Medical Offi… | SELL | $100K–$500K | 106K | $2.60 | May 3, 2023 |
| Hahn Mark W | CFO | SELL | $1M+ | 456K | $2.58 | May 3, 2023 |
| ZACCARDELLI DAVID | President and CEO | SELL | $1M+ | 456K | $2.58 | May 3, 2023 |
| Hahn Mark W | CFO | SELL | $1M+ | 413K | $2.56 | Feb 3, 2023 |
| ZACCARDELLI DAVID | President and CEO | SELL | $1M+ | 433K | $2.56 | Feb 3, 2023 |
| Rickard Kathleen A. | Chief Medical Offi… | SELL | $100K–$500K | 119K | $2.55 | Feb 3, 2023 |
| Rickard Kathleen A. | Chief Medical Offi… | EXERCISE | N/A | 105K | — | Feb 3, 2023 |
| Poll Claire | General Counsel | EXERCISE | N/A | 179K | — | Feb 3, 2023 |
| Poll Claire | General Counsel | SELL | $100K–$500K | 152K | $2.59 | Feb 3, 2023 |
| Poll Claire | General Counsel | SELL | $500K+ | 240K | $2.69 | Dec 27, 2022 |
| ORBIMED ADVISORS LLC | Director | SELL | $1M+ | 6.1M | $22.15 | Dec 27, 2022 |
| Gupta Rishi | Director | SELL | $1M+ | 6.1M | $22.15 | Dec 27, 2022 |
| ZACCARDELLI DAVID | President and CEO | SELL | $1M+ | 600K | $2.12 | Dec 21, 2022 |
| Hahn Mark W | CFO | SELL | $1M+ | 600K | $2.12 | Dec 21, 2022 |
| ZACCARDELLI DAVID | President and CEO | SELL | $50K–$100K | 33K | $1.67 | Nov 3, 2022 |
| Rickard Kathleen A. | Chief Medical Offi… | SELL | $15K–$50K | 29K | $1.64 | Nov 3, 2022 |
| Hahn Mark W | CFO | SELL | $15K–$50K | 13K | $1.67 | Nov 3, 2022 |
| Access Industries Holdings LLC | 10% Owner | BUY | $1M+ | 4.8M | $1.31 | Aug 17, 2022 |
| ZACCARDELLI DAVID | President and CEO | SELL | $1M+ | 600K | $1.75 | Aug 12, 2022 |
| Hahn Mark W | CFO | SELL | $1M+ | 600K | $1.75 | Aug 12, 2022 |
| ZACCARDELLI DAVID | President and CEO | SELL | $15K–$50K | 33K | $0.70 | Aug 3, 2022 |
| Rickard Kathleen A. | Chief Medical Offi… | SELL | $15K–$50K | 29K | $0.70 | Aug 3, 2022 |
| Hahn Mark W | CFO | SELL | $1K–$15K | 13K | $0.70 | Aug 3, 2022 |
| ZACCARDELLI DAVID | President and CEO | SELL | $15K–$50K | 33K | $0.50 | May 5, 2022 |
| Rickard Kathleen A. | Chief Medical Offi… | SELL | $1K–$15K | 29K | $0.49 | May 5, 2022 |
| Hahn Mark W | CFO | SELL | $1K–$15K | 13K | $0.50 | May 5, 2022 |
| Rickard Kathleen A. | Chief Medical Offi… | SELL | $50K–$100K | 173K | $0.57 | Apr 12, 2022 |
| Deschamps Lisa | Director | SELL | $1K–$15K | 12K | $0.78 | Feb 3, 2022 |
| ZACCARDELLI DAVID | President and CEO | SELL | $15K–$50K | 52K | $0.73 | Feb 3, 2022 |
| ZACCARDELLI DAVID | President and CEO | GRANT | $100K–$500K | 334K | $0.75 | Feb 3, 2022 |
| Hahn Mark W | CFO | SELL | $1K–$15K | 10K | $0.76 | Feb 3, 2022 |
| Hahn Mark W | CFO | GRANT | $50K–$100K | 134K | $0.75 | Feb 3, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 1 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| DekaBank Deutsche Girozentrale | 20K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Pentwater Capital Management LP
SC 13G · Nov 14, 2025
0.0%
0 shares
SC 13G/A · Nov 14, 2025
0.0%
0 shares
SC 13G/A · Nov 14, 2025
1.2%
1.0M shares
SC 13G/A · Aug 14, 2025
0.7%
594K shares
SC 13G/A · Aug 14, 2025
6.4%
5.5M shares
SC 13G/A · Aug 14, 2025
7.2%
6.1M shares
SC 13G/A · May 15, 2025
7.1%
6.0M shares
SC 13G · May 14, 2025
6.5%
5.5M shares
SC 13G/A · Feb 14, 2025
8.9%
7.8M shares
SC 13G/A · Feb 14, 2025
3.8%
25.0M shares
Growth Equity Opportunities 17, LLC
SC 13D/A · Jan 22, 2025
5.0%
32.7M shares
SC 13G/A · Nov 14, 2024
10.0%
8.5M shares
SC 13G/A · Nov 14, 2024
8.1%
6.6M shares
SC 13G · Nov 14, 2024
5.2%
33.7M shares
SC 13G/A · Nov 14, 2024
3.9%
25.4M shares
SC 13G/A · Nov 14, 2024
3.1%
20.3M shares
Growth Equity Opportunities 17, LLC
SC 13D/A · Aug 29, 2024
6.9%
44.7M shares
SC 13G · Jul 30, 2024
6.3%
5.1M shares
SC 13G · Jul 12, 2024
5.1%
32.9M shares
SC 13G/A · Feb 14, 2024
10.0%
7.5M shares
SC 13G/A · Feb 14, 2024
4.8%
3.9M shares
SC 13D/A · May 16, 2023
4.8%
3.8M shares
SC 13G/A · Apr 25, 2023
0.0%
0 shares
SC 13G · Apr 20, 2023
5.6%
4.5M shares
SC 13G/A · Feb 14, 2023
10.0%
7.7M shares
SC 13G/A · Feb 13, 2023
3.8%
23.1M shares
SC 13G/A · Feb 9, 2023
5.5%
32.9M shares
SC 13D/A · Dec 27, 2022
5.6%
4.3M shares
Growth Equity Opportunities 17, LLC
SC 13D/A · Sep 7, 2022
7.9%
46.4M shares
SC 13D/A · Aug 12, 2022
6.9%
5.0M shares
SC 13D/A · Aug 11, 2022
4.4%
21.3M shares
SC 13G/A · Aug 10, 2022
10.5%
51.1M shares
SC 13G/A · Feb 14, 2022
10.0%
48.8M shares
SC 13G/A · Feb 11, 2022
0.0%
0 shares